Dysglycaemia, inflammation and psychosis: findings from the UK ALSPAC birth cohort

Perry, Benjamin Ian, Upthegrove, Rachel, Thompson, Andrew, Marwaha, Steven, Zammit, Stanley ORCID: https://orcid.org/0000-0002-2647-9211, Singh, Swaran Preet and Khandaker, Golam 2019. Dysglycaemia, inflammation and psychosis: findings from the UK ALSPAC birth cohort. Schizophrenia Bulletin 45 (24 Feb) , pp. 330-338. 10.1093/schbul/sby040

Preview

PDF - Accepted Post-Print Version Download (124kB) | Preview

Abstract

Background Psychosis is associated with both dysglycaemia and low-grade inflammation, but population-based studies investigating the interplay between these factors are scarce. Aims (1) To explore the direction of association between markers of dysglycaemia, inflammation and psychotic experiences (PEs); and (2) To explore whether dysglycaemia moderates and/or mediates the association between inflammation and PEs. Method Data from the Avon Longitudinal Study of Parents and Children (ALSPAC) birth cohort were modeled using logistic and linear regression to examine cross-sectional and longitudinal associations between markers of dysglycaemia (ages 9 and 18), interleukin-6 (IL-6) (age 9), and PEs (ages 12 and 18). We tested for an interaction between dysglycaemia and IL-6 on risk of PEs at age 18, and tested whether dysglycaemia mediated the relationship between IL-6 and PEs. Results Based on 2627 participants, at age 18, insulin resistance (IR) was associated with PEs (adjusted OR = 2.32; 95% CI, 1.37–3.97). IR was associated with IL-6 both cross-sectionally and longitudinally. Interaction analyses under a multiplicative model showed that IR moderated the association between IL-6 at age 9 and PEs at age 18 (adjusted OR for interaction term = 2.18; 95% C.I., 1.06–4.49). Mediation analysis did not support a model of IR mediating the relationship between IL-6 and PEs. Implications IR is associated with PEs in young people even before the onset of clinical psychosis. Metabolic alterations may interact with childhood inflammation to increase risk of PEs. The findings have implications for clinical practice and future research.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG)
Publisher:	Oxford University Press
ISSN:	0586-7614
Date of First Compliant Deposit:	19 April 2018
Date of Acceptance:	15 March 2018
Last Modified:	05 May 2023 09:45
URI:	https://orca.cardiff.ac.uk/id/eprint/110807

Citation Data

Cited 33 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item